XML 74 R30.htm IDEA: XBRL DOCUMENT v3.23.2
SEGMENT DATA AND RELATED INFORMATION
 12 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
SEGMENT DATA AND RELATED INFORMATION SEGMENT DATA AND RELATED INFORMATION
Reportable operating segments include components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (the “Chief Executive”) in deciding how to allocate resources and in assessing performance. As a result of the similarities in the manufacturing, marketing and distribution processes for all of the Company’s products, much of the information provided in the consolidated financial statements is similar to, or the same as, that reviewed on a regular basis by the Chief Executive. Although the Company operates in one business segment, beauty products, management also evaluates performance on a product category basis. While the Company’s results of operations are also reviewed on a consolidated basis, the Chief Executive reviews data segmented on a basis that facilitates comparison to industry statistics. Accordingly, net sales, depreciation and amortization, and operating income are available with respect to the manufacture and distribution of skin care, makeup, fragrance, hair care and other products. These product categories meet the definition of operating segments and, accordingly, additional financial data are provided below. The other segment includes the sales and related results of ancillary products and services that do not fit the definition of skin care, makeup, fragrance and hair care, including royalty revenue associated with the license of the TOM FORD trademark as discussed in Note 14 - Revenue Recognition. Product category performance is measured based upon net sales before returns associated with restructuring and other activities, and earnings before income taxes, other components of net periodic benefit cost, interest expense, interest income and investment income, net, other income, net and charges associated with restructuring and other activities. Returns and charges associated with restructuring and other activities are not allocated to the Company's product categories or geographic regions because they are centrally directed and controlled, are not included in internal measures of product category or geographic region performance and result from activities that are deemed Company-wide initiatives to redesign, resize and reorganize select areas of the business.
 
The accounting policies for the Company’s reportable segments are substantially the same as those described in the summary of significant accounting policies, except for depreciation and amortization charges, which are allocated, primarily, based upon net sales. The assets and liabilities of the Company are managed centrally and are reported internally in the same manner as the consolidated financial statements; thus, no additional information is produced for the Chief Executive or included herein.
 Year Ended June 30
(In millions)202320222021
PRODUCT CATEGORY DATA   
Net sales:   
Skin Care$8,202 $9,886 $9,484 
Makeup4,516 4,667 4,203 
Fragrance2,512 2,508 1,926 
Hair Care653 631 571 
Other54 49 45 
15,937 17,741 16,229 
Returns associated with restructuring and other activities(27)(4)(14)
Net sales$15,910 $17,737 $16,215 
Depreciation and amortization:
Skin Care$383 $404 $330 
Makeup211 213 210 
Fragrance117 89 78 
Hair Care31 20 31 
Other2 1 2 
$744 $727 $651 
Operating income (loss) before charges associated with restructuring and other activities:
Skin Care$1,204 $2,753 $3,036 
Makeup(22)133 (384)
Fragrance440 456 215 
Hair Care(34)(28)(19)
Other6 — (2)
1,594 3,314 2,846 
Reconciliation:
Charges associated with restructuring and other activities(85)(144)(228)
Interest expense(255)(167)(173)
Interest income and investment income, net131 30 51 
Other components of net periodic benefit cost12 2 (12)
Other income, net— 1 847 
Earnings before income taxes$1,397 $3,036 $3,331 
 Year Ended June 30
(In millions)202320222021
GEOGRAPHIC DATA(1)
Net sales:
The Americas$4,518 $4,623 $3,797 
Europe, the Middle East & Africa6,225 7,681 6,946 
Asia/Pacific5,194 5,437 5,486 
15,937 17,741 16,229 
Returns associated with restructuring and other activities(27)(4)(14)
Net sales$15,910 $17,737 $16,215 
Operating income (loss):
The Americas$(73)$1,159 $518 
Europe, the Middle East & Africa843 1,360 1,335 
Asia/Pacific824 795 993 
1,594 3,314 2,846 
Charges associated with restructuring and other activities(85)(144)(228)
Operating income$1,509 $3,170 $2,618 
Total assets:
The Americas$13,292 $10,989 $11,387 
Europe, the Middle East & Africa5,985 5,781 5,907 
Asia/Pacific4,138 4,140 4,677 
$23,415 $20,910 $21,971 
Long-lived assets(2):
The Americas$2,593 $2,609 $2,521 
Europe, the Middle East & Africa1,202 1,133 1,314 
Asia/Pacific1,181 857 635 
$4,976 $4,599 $4,470 
(1)The net sales from the Company’s travel retail business are included in the Europe, the Middle East & Africa region, with the exception of net sales of Dr.Jart+ in the travel retail channel that are reflected in Korea in the Asia/Pacific region. Operating income attributable to the travel retail sales included in Europe, the Middle East & Africa is included in that region and in The Americas.
(2)Includes property, plant and equipment, net and operating lease ROU assets.

Net sales are predominantly attributed to a country within a geographic region based on the location of the customer. The Company is domiciled in the United States. Net sales in the United States, including net sales from travel retail locations, in fiscal 2023, 2022 and 2021 were $3,848 million, $4,009 million and $3,356 million, respectively. Net sales in mainland China, as well as net sales from travel retail locations, in fiscal 2023, 2022 and 2021 were approximately 28%, 34% and 36% of consolidated net sales, respectively. In fiscal 2023 and 2022, net sales in Korea, including net sales from travel retail locations, were approximately 10% and 11%, respectively, and no other country represented greater than 10% of the Company’s consolidated net sales. 
The Company’s long-lived assets in the United States at June 30, 2023, 2022 and 2021 were $2,136 million, $2,153 million and $2,075 million, respectively.